ELDN Eledon Pharmaceuticals 8-K2021Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook
5 Jan 21
Files
SEC
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
ELDN 8-K Filings
- 7 Jan 21 Unregistered Sales of Equity Securities
- 5 Jan 21 Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook
- 22 Dec 20 Submission of Matters to a Vote of Security Holders
- 10 Dec 20 Amendments to Articles of Incorporation or Bylaws
- 20 Nov 20 Amendments to Articles of Incorporation or Bylaws
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…